Click for best price
Brain Disease Market Size, Share 2023
Brain diseases a part of central nervous system diseases, is a condition where the brain structure or functions alter. The brain diseases include conditions or disabilities that affect the brain. Mostly brain disorders occur due to traumatic injury, genetic or other diseases, while a small number of brain diseases occur due to environmental factors. The major concerned brain disease are caused due to brain deterioration which may lead to neurodegenerative diseases such as Alzheimer?s, Huntington?s disease, and others. The mental disorders or mental illness occurrence is also related to the brain diseases, which include depression, anxiety, bipolar disorders, and others. ?The etiology of brain disease is not specific. It can occur to anyone and the risk factors of brain diseases differ in accordance to the different types of brain diseases. The sign and symptoms also differ for every brain diseases. Some of the most common symptoms include headache, memory loss, tremors, increased reflexes, slurred speech, paralysis, and inability to concentrate among others. Moreover, the treatment of brain diseases range from surgery to rehabilitation to medications; depending upon the brain disease the patient is affected by. The brain diseases are progressive which may affect the daily life of patients and hence should be immediately treated upon their diagnosis or detection.
This report aims to provide a comprehensive presentation of the global market for Brain Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Disease. This report contains market size and forecasts of Brain Disease in global, including the following market information:
Global Brain Disease Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Brain Disease market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The incidence and prevalence of brain diseases and disorders increase with age. The growing baby booming population is the major factor driving the brain disease market, globally. Rising prevalence of brain diseases is expected to boost the growth of the market. Due lack of effective treatment for some brain diseases such as brain cancer, they are a huge demand for medicinal treatment. Because of this reason, key market players are intensively focusing on R&D to develop a safe and effective treatment for brain diseases. All these factors act as driver for burgeoning growth of the brain disease market. However, adverse effects associated with the medications of brain diseases is anticipated to hinder the market growth.
We surveyed the Brain Disease companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Brain Disease Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Brain Disease Market Segment Percentages, by Type, 2022 (%)
Brain Cancer
Alzheimer Disease
Alcoholism
Amnesia
Epilepsy
Meningitis
Others
Global Brain Disease Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Brain Disease Market Segment Percentages, by Application, 2022 (%)
Hospitals Pharmacy
Online Pharmacy
Pharmacy
Global Brain Disease Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Brain Disease Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Brain Disease revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Brain Disease revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Eli Lilly
F. Hoffmann La Roche
GE Healthcare
Janssen Pharmaceuticals
Abbvie
AC Immune
Allergan
Merck
Novartis
AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Brain Disease, market overview.
Chapter 2: Global Brain Disease market size in revenue.
Chapter 3: Detailed analysis of Brain Disease company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Brain Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Brain Disease Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Brain Disease Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Brain Disease Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Brain Disease Overall Market Size
2.1 Global Brain Disease Market Size: 2022 VS 2029
2.2 Global Brain Disease Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Brain Disease Players in Global Market
3.2 Top Global Brain Disease Companies Ranked by Revenue
3.3 Global Brain Disease Revenue by Companies
3.4 Top 3 and Top 5 Brain Disease Companies in Global Market, by Revenue in 2022
3.5 Global Companies Brain Disease Product Type
3.6 Tier 1, Tier 2 and Tier 3 Brain Disease Players in Global Market
3.6.1 List of Global Tier 1 Brain Disease Companies
3.6.2 List of Global Tier 2 and Tier 3 Brain Disease Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Brain Disease Market Size Markets, 2022 & 2029
4.1.2 Brain Cancer
4.1.3 Alzheimer Disease
4.1.4 Alcoholism
4.1.5 Amnesia
4.1.6 Epilepsy
4.1.7 Meningitis
4.1.8 Others
4.2 By Type - Global Brain Disease Revenue & Forecasts
4.2.1 By Type - Global Brain Disease Revenue, 2018-2023
4.2.2 By Type - Global Brain Disease Revenue, 2024-2029
4.2.3 By Type - Global Brain Disease Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Brain Disease Market Size, 2022 & 2029
5.1.2 Hospitals Pharmacy
5.1.3 Online Pharmacy
5.1.4 Pharmacy
5.2 By Application - Global Brain Disease Revenue & Forecasts
5.2.1 By Application - Global Brain Disease Revenue, 2018-2023
5.2.2 By Application - Global Brain Disease Revenue, 2024-2029
5.2.3 By Application - Global Brain Disease Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Brain Disease Market Size, 2022 & 2029
6.2 By Region - Global Brain Disease Revenue & Forecasts
6.2.1 By Region - Global Brain Disease Revenue, 2018-2023
6.2.2 By Region - Global Brain Disease Revenue, 2024-2029
6.2.3 By Region - Global Brain Disease Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Brain Disease Revenue, 2018-2029
6.3.2 US Brain Disease Market Size, 2018-2029
6.3.3 Canada Brain Disease Market Size, 2018-2029
6.3.4 Mexico Brain Disease Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Brain Disease Revenue, 2018-2029
6.4.2 Germany Brain Disease Market Size, 2018-2029
6.4.3 France Brain Disease Market Size, 2018-2029
6.4.4 U.K. Brain Disease Market Size, 2018-2029
6.4.5 Italy Brain Disease Market Size, 2018-2029
6.4.6 Russia Brain Disease Market Size, 2018-2029
6.4.7 Nordic Countries Brain Disease Market Size, 2018-2029
6.4.8 Benelux Brain Disease Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Brain Disease Revenue, 2018-2029
6.5.2 China Brain Disease Market Size, 2018-2029
6.5.3 Japan Brain Disease Market Size, 2018-2029
6.5.4 South Korea Brain Disease Market Size, 2018-2029
6.5.5 Southeast Asia Brain Disease Market Size, 2018-2029
6.5.6 India Brain Disease Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Brain Disease Revenue, 2018-2029
6.6.2 Brazil Brain Disease Market Size, 2018-2029
6.6.3 Argentina Brain Disease Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Brain Disease Revenue, 2018-2029
6.7.2 Turkey Brain Disease Market Size, 2018-2029
6.7.3 Israel Brain Disease Market Size, 2018-2029
6.7.4 Saudi Arabia Brain Disease Market Size, 2018-2029
6.7.5 UAE Brain Disease Market Size, 2018-2029
7 Brain Disease Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Brain Disease Major Product Offerings
7.1.4 Pfizer Brain Disease Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Company Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Brain Disease Major Product Offerings
7.2.4 Eli Lilly Brain Disease Revenue in Global Market (2018-2023)
7.2.5 Eli Lilly Key News & Latest Developments
7.3 F. Hoffmann La Roche
7.3.1 F. Hoffmann La Roche Company Summary
7.3.2 F. Hoffmann La Roche Business Overview
7.3.3 F. Hoffmann La Roche Brain Disease Major Product Offerings
7.3.4 F. Hoffmann La Roche Brain Disease Revenue in Global Market (2018-2023)
7.3.5 F. Hoffmann La Roche Key News & Latest Developments
7.4 GE Healthcare
7.4.1 GE Healthcare Company Summary
7.4.2 GE Healthcare Business Overview
7.4.3 GE Healthcare Brain Disease Major Product Offerings
7.4.4 GE Healthcare Brain Disease Revenue in Global Market (2018-2023)
7.4.5 GE Healthcare Key News & Latest Developments
7.5 Janssen Pharmaceuticals
7.5.1 Janssen Pharmaceuticals Company Summary
7.5.2 Janssen Pharmaceuticals Business Overview
7.5.3 Janssen Pharmaceuticals Brain Disease Major Product Offerings
7.5.4 Janssen Pharmaceuticals Brain Disease Revenue in Global Market (2018-2023)
7.5.5 Janssen Pharmaceuticals Key News & Latest Developments
7.6 Abbvie
7.6.1 Abbvie Company Summary
7.6.2 Abbvie Business Overview
7.6.3 Abbvie Brain Disease Major Product Offerings
7.6.4 Abbvie Brain Disease Revenue in Global Market (2018-2023)
7.6.5 Abbvie Key News & Latest Developments
7.7 AC Immune
7.7.1 AC Immune Company Summary
7.7.2 AC Immune Business Overview
7.7.3 AC Immune Brain Disease Major Product Offerings
7.7.4 AC Immune Brain Disease Revenue in Global Market (2018-2023)
7.7.5 AC Immune Key News & Latest Developments
7.8 Allergan
7.8.1 Allergan Company Summary
7.8.2 Allergan Business Overview
7.8.3 Allergan Brain Disease Major Product Offerings
7.8.4 Allergan Brain Disease Revenue in Global Market (2018-2023)
7.8.5 Allergan Key News & Latest Developments
7.9 Merck
7.9.1 Merck Company Summary
7.9.2 Merck Business Overview
7.9.3 Merck Brain Disease Major Product Offerings
7.9.4 Merck Brain Disease Revenue in Global Market (2018-2023)
7.9.5 Merck Key News & Latest Developments
7.10 Novartis
7.10.1 Novartis Company Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Brain Disease Major Product Offerings
7.10.4 Novartis Brain Disease Revenue in Global Market (2018-2023)
7.10.5 Novartis Key News & Latest Developments
7.11 AstraZeneca
7.11.1 AstraZeneca Company Summary
7.11.2 AstraZeneca Business Overview
7.11.3 AstraZeneca Brain Disease Major Product Offerings
7.11.4 AstraZeneca Brain Disease Revenue in Global Market (2018-2023)
7.11.5 AstraZeneca Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Brain Disease Market Opportunities & Trends in Global Market
Table 2. Brain Disease Market Drivers in Global Market
Table 3. Brain Disease Market Restraints in Global Market
Table 4. Key Players of Brain Disease in Global Market
Table 5. Top Brain Disease Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Brain Disease Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Brain Disease Revenue Share by Companies, 2018-2023
Table 8. Global Companies Brain Disease Product Type
Table 9. List of Global Tier 1 Brain Disease Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Brain Disease Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Brain Disease Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Brain Disease Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Brain Disease Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Brain Disease Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Brain Disease Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Brain Disease Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Brain Disease Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Brain Disease Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Brain Disease Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Brain Disease Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Brain Disease Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Brain Disease Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Brain Disease Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Brain Disease Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Brain Disease Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Brain Disease Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Brain Disease Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Brain Disease Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Brain Disease Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Brain Disease Product Offerings
Table 32. Pfizer Brain Disease Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Eli Lilly Company Summary
Table 35. Eli Lilly Brain Disease Product Offerings
Table 36. Eli Lilly Brain Disease Revenue (US$, Mn) & (2018-2023)
Table 37. Eli Lilly Key News & Latest Developments
Table 38. F. Hoffmann La Roche Company Summary
Table 39. F. Hoffmann La Roche Brain Disease Product Offerings
Table 40. F. Hoffmann La Roche Brain Disease Revenue (US$, Mn) & (2018-2023)
Table 41. F. Hoffmann La Roche Key News & Latest Developments
Table 42. GE Healthcare Company Summary
Table 43. GE Healthcare Brain Disease Product Offerings
Table 44. GE Healthcare Brain Disease Revenue (US$, Mn) & (2018-2023)
Table 45. GE Healthcare Key News & Latest Developments
Table 46. Janssen Pharmaceuticals Company Summary
Table 47. Janssen Pharmaceuticals Brain Disease Product Offerings
Table 48. Janssen Pharmaceuticals Brain Disease Revenue (US$, Mn) & (2018-2023)
Table 49. Janssen Pharmaceuticals Key News & Latest Developments
Table 50. Abbvie Company Summary
Table 51. Abbvie Brain Disease Product Offerings
Table 52. Abbvie Brain Disease Revenue (US$, Mn) & (2018-2023)
Table 53. Abbvie Key News & Latest Developments
Table 54. AC Immune Company Summary
Table 55. AC Immune Brain Disease Product Offerings
Table 56. AC Immune Brain Disease Revenue (US$, Mn) & (2018-2023)
Table 57. AC Immune Key News & Latest Developments
Table 58. Allergan Company Summary
Table 59. Allergan Brain Disease Product Offerings
Table 60. Allergan Brain Disease Revenue (US$, Mn) & (2018-2023)
Table 61. Allergan Key News & Latest Developments
Table 62. Merck Company Summary
Table 63. Merck Brain Disease Product Offerings
Table 64. Merck Brain Disease Revenue (US$, Mn) & (2018-2023)
Table 65. Merck Key News & Latest Developments
Table 66. Novartis Company Summary
Table 67. Novartis Brain Disease Product Offerings
Table 68. Novartis Brain Disease Revenue (US$, Mn) & (2018-2023)
Table 69. Novartis Key News & Latest Developments
Table 70. AstraZeneca Company Summary
Table 71. AstraZeneca Brain Disease Product Offerings
Table 72. AstraZeneca Brain Disease Revenue (US$, Mn) & (2018-2023)
Table 73. AstraZeneca Key News & Latest Developments
List of Figures
Figure 1. Brain Disease Segment by Type in 2022
Figure 2. Brain Disease Segment by Application in 2022
Figure 3. Global Brain Disease Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Brain Disease Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Brain Disease Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Brain Disease Revenue in 2022
Figure 8. By Type - Global Brain Disease Revenue Market Share, 2018-2029
Figure 9. By Application - Global Brain Disease Revenue Market Share, 2018-2029
Figure 10. By Type - Global Brain Disease Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Brain Disease Revenue Market Share, 2018-2029
Figure 12. By Application - Global Brain Disease Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Brain Disease Revenue Market Share, 2018-2029
Figure 14. By Region - Global Brain Disease Revenue Market Share, 2018-2029
Figure 15. By Country - North America Brain Disease Revenue Market Share, 2018-2029
Figure 16. US Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Brain Disease Revenue Market Share, 2018-2029
Figure 20. Germany Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 21. France Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Brain Disease Revenue Market Share, 2018-2029
Figure 28. China Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 32. India Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Brain Disease Revenue Market Share, 2018-2029
Figure 34. Brazil Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Brain Disease Revenue Market Share, 2018-2029
Figure 37. Turkey Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Brain Disease Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Brain Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eli Lilly Brain Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. F. Hoffmann La Roche Brain Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GE Healthcare Brain Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Janssen Pharmaceuticals Brain Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Abbvie Brain Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AC Immune Brain Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Allergan Brain Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Merck Brain Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Novartis Brain Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. AstraZeneca Brain Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
